News Search

Target ALS, a consortium of at least 18 laboratories, including ones at CUMC and at Johns Hopkins, will work to find biological “targets,” that could be used to test potential drug therapies for ALS. CUMC's Christopher E. Henderson is Target ALS's scientific director.

CUMC neuroscientist Asa Abeliovich and his team have identified a protein trafficking defect within brain cells that may underlie common non-familial forms of Parkinson's disease.

Columbia University Medical Center hearing specialist, Dr. Anil K. Lalwani, comments on age-related hearing loss.

The 2012 P&S Awards for Excellence were presented January 31 in a ceremony at the Faculty Club in front of a crowd of department chairs, faculty, and staff.